A Randomized, Prospective and Crossover Study, Comparing the Eradication Rate After 10 Days of Concomitant Therapy to Bismuth Quadruple Therapy Among a Sample of the Lebanese Population

ABSTRACT: Background: Concomitant therapy and bismuth quadruple therapy are both recommended as first-line treatment regimens for the empiric treatment of Helicobacter pylori infection, especially after the increased resistance to clarithromycin. Objective: Our goal was to compare both treatment re...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jad Chidiac, MD, Reine-Marie Kahwaji, MD, Souheil Hallit, PharmD, MSc, MPH, PhD, Yara Yazbeck, MD, Bassem Akiki, MD, Charbel Yazbeck, MD
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	Current Therapeutic Research
Subjects:	Bismuth quadruple therapy Concomitant therapy Eradication Helicobacter pylori First-line therapy regimen Second-line therapy regimen
Online Access:	http://www.sciencedirect.com/science/article/pii/S0011393X25000165
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

A Randomized, Prospective and Crossover Study, Comparing the Eradication Rate After 10 Days of Concomitant Therapy to Bismuth Quadruple Therapy Among a Sample of the Lebanese Population

Similar Items